Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines
Objective: Ankaferd hemostat is the first topical hemostatic agent about the red blood cell–fibrinogen relations tested in the clinical trials. Ankaferd hemostat consists of standardized plant extracts including Alpinia officinarum, Glycyrrhiza glabra, Thymus vulgaris, Urtica dioica , and Vitis vini...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-02-01
|
| Series: | SAGE Open Medicine |
| Online Access: | https://doi.org/10.1177/2050312116689519 |